Valenza G
Dienststelle Erlangen, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Eggenreuther Weg 43, 91058, Erlangen, Deutschland.
Med Klin Intensivmed Notfmed. 2019 Apr;114(3):263-275. doi: 10.1007/s00063-019-0547-x. Epub 2019 Mar 1.
In Germany, multidrug-resistant gram-negative rods (MRGN) are classified in two groups, namely those with resistance against three (3MRGN) and those with resistance against four (4MRGN) of the following antibiotic groups: acylureidopenicillins, third or fourth generation cephalosporins, fluoroquinolones and carbapenemes. The rate of 3MRGN enterobacteria and 4MRGN Pseudomonas aeruginosa has significantly increased in German intensive care units from 2008-2014. In contrast, 4MRGN enterobacteria are still rare. The 3MRGN and 4MRGN phenotypes can be associated with different antimicrobial resistance mechanisms such as the production of extended-spectrum β‑lactamases (ESBL) or carbapenemases. The strategy for the prevention and control of MRGN in intensive care units includes basic hygiene measures as well as special measures such as contact isolation of patients. The treatment of MRGN infections should be carried out according to the antimicrobial susceptibility test results.
在德国,多重耐药革兰氏阴性菌(MRGN)分为两组,即对以下抗生素组中的三种(3MRGN)和四种(4MRGN)具有耐药性的细菌:酰脲类青霉素、第三代或第四代头孢菌素、氟喹诺酮类和碳青霉烯类。2008年至2014年期间,德国重症监护病房中3MRGN肠杆菌和4MRGN铜绿假单胞菌的发生率显著增加。相比之下,4MRGN肠杆菌仍然很少见。3MRGN和4MRGN表型可能与不同的抗菌耐药机制有关,如超广谱β-内酰胺酶(ESBL)或碳青霉烯酶的产生。重症监护病房中预防和控制MRGN的策略包括基本卫生措施以及特殊措施,如对患者进行接触隔离。MRGN感染的治疗应根据抗菌药敏试验结果进行。